“We did not develop this medicine [Nexavar] for Indians, we developed it for western patients who can afford it.” These inflammatory words, uttered by Bayer AG Chairman Marijn Dekkers at a Financial Times global pharmaceutical forum last month, have flared into an international firestorm,...Read More 